Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment ...

In motivated alcohol-dependent patients who are compliant with medication schedules, disulfiram is effective at increasing consecutive days of abstinence from alcohol. Naltrexone is an opioid ...

Fibromyalgia treatment focuses on a combination therapy approach to help you manage chronic pain. Cognitive behavioral therapy (CBT), to help you restructure how you think about pain, is generally ...

TNX-102 SL is a non-opioid, centrally-acting analgesic administered at bedtime for the treatment of fibromyalgia. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ...

These spasms can happen due to injuries, conditions like fibromyalgia or multiple sclerosis, or as a side effect of other treatments. Muscle relaxants are a common choice for healthcare providers, ...

According to the Centers for Disease Control and Prevention (CDC), 2 in 5 people in the United States have obesity. The obesity rate was 30.5% from 1999 to 2000. From 2017 to 2020, it increased to ...

Dec. 22, 2023 — There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia. Both forms of treatment produced a ...

In fact, a 2016 review of studies on treating fibromyalgia said that exercise was the only treatment that had strong evidence of being effective. However, that research may have certain flaws or ...

Fibromyalgia affects more than 10 million adults in the U.S. who are mostly women TNX-102 SL has the potential to be the first member of a new class of analgesic drugs for fibromyalgia and the first ...

TNX-102 SL was granted Fast Track designation for fibromyalgia by the FDA in July of 2024. Fast Track is designed to expedite FDA review of important new drugs to treat serious conditions and fill ...

not many people are aware of it or take advantage of it so what I’ve been doing over these last 10-15 years is trying to educate the public about how affective medications can be to help people in ...

TNX-102 SL was granted Fast Track designation for fibromyalgia by the FDA in July of 2024. Fast Track is designed to expedite FDA review of important new drugs to treat serious conditions and fill an ...